{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:12Z","timestamp":1791869052792,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.semradonc.2023.12.003","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T23:40:58Z","timestamp":1710805258000},"page":"180-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma"],"prefix":"10.1016","volume":"34","author":[{"given":"B. Ashleigh","family":"Guadagnolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J Clin Oncol"},{"issue":"9325","key":"10.1016\/j.semradonc.2023.12.003_bib0003","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0004","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","article-title":"Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma","volume":"14","author":"Pisters","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-198209000-00009","article-title":"The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy","volume":"196","author":"Rosenberg","year":"1982","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.semradonc.2023.12.003_bib0006","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0360-3016(91)90324-W","article-title":"Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma","volume":"21","author":"Stinson","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2023.12.003_bib0007","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0360-3016(02)04510-8","article-title":"Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: A retrospective comparative evaluation of disease outcome","volume":"56","author":"Zagars","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.semradonc.2023.12.003_bib0008","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.22298","article-title":"Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas","volume":"107","author":"Cannon","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.prro.2021.04.005","article-title":"Radiation Therapy for treatment of soft tissue sarcoma in adults: Executive summary of an ASTRO clinical practice guideline","volume":"11","author":"Salerno","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.semradonc.2023.12.003_bib0011","doi-asserted-by":"crossref","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, Version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.semradonc.2023.12.003_bib0012","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2023.12.003_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"10237","key":"10.1016\/j.semradonc.2023.12.003_bib0014","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): A multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0016","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0889-8588(18)30073-X","article-title":"Preoperative therapy for soft tissue sarcoma","volume":"9","author":"Eilber","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3735874","article-title":"Evaluating thresholds to adopt hypofractionated preoperative radiotherapy as standard of care in sarcoma","volume":"2021","author":"Valle","year":"2021","journal-title":"Sarcoma"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0018","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2022.02.009","article-title":"How low can you go? The radiobiology of hypofractionation","volume":"34","author":"Brand","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0019","series-title":"Basic Clinical Radiobiology","first-page":"99","article-title":"Fractionation: The linear-quadratic approach","author":"Joiner","year":"2019"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0020","series-title":"Basic Clinical Radiobiology","first-page":"112","article-title":"The linear-quadratic approach in clinical practice","author":"Bentzen","year":"2019"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1667\/RADE-20-00226.1","article-title":"Cellular radiosensitivity of soft tissue sarcoma","volume":"196","author":"Haas","year":"2021","journal-title":"Radiat Res"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2015.12.002","article-title":"Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies","volume":"119","author":"Haas","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0023","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0024","doi-asserted-by":"crossref","first-page":"01TR01","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys Med Biol"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clon.2015.02.001","article-title":"The radiobiology of hypofractionation","volume":"27","author":"Nahum","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0026","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00000658-198010000-00001","article-title":"Is amputation necessary for sarcomas? A seven-year experience with limb salvage","volume":"192","author":"Eilber","year":"1980","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0027","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/1097-0142(19840615)53:12<2579::AID-CNCR2820531202>3.0.CO;2-V","article-title":"Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy","volume":"53","author":"Eilber","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4615-3082-4_9","article-title":"Preoperative chemotherapy for soft tissue sarcomas of the extremities: The experience at the University of California, Los Angeles","volume":"67","author":"Engel","year":"1993","journal-title":"Cancer Treat Res"},{"issue":"13","key":"10.1016\/j.semradonc.2023.12.003_bib0029","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0030","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","article-title":"Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas","volume":"41","author":"Pennington","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.semradonc.2023.12.003_bib0031","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1245\/ASO.2005.03.064","article-title":"Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma","volume":"12","author":"Mack","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0032","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1245\/s10434-018-6346-4","article-title":"Epirubicin and ifosfamide with preoperative radiation for high-risk soft tissue sarcomas","volume":"25","author":"Lu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2021.02.019","article-title":"Combined preoperative hypofractionated radiotherapy with doxorubicin-ifosfamide chemotherapy in marginally resectable soft tissue sarcomas: Results of a phase 2 clinical trial","volume":"110","author":"Spa\u0142ek","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0034","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13014-022-02072-9","article-title":"Preoperative hypofractionated radiotherapy for soft tissue sarcomas: A systematic review","volume":"17","author":"Roohani","year":"2022","journal-title":"Radiat Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0035","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.3390\/cancers13122981","article-title":"Efficacy and safety of hypofractionated preoperative radiotherapy for primary locally advanced soft tissue sarcomas of limbs or trunk wall","volume":"13","author":"Kose\u0142a-Paterczyk","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109439","article-title":"Early outcomes of ultra-hypofractionated preoperative radiation therapy for soft tissue sarcoma followed by immediate surgical resection","volume":"180","author":"Mayo","year":"2023","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.semradonc.2023.12.003_bib0037","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","article-title":"A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma","volume":"26","author":"Kalbasi","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"20","key":"10.1016\/j.semradonc.2023.12.003_bib0038","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","article-title":"Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial","volume":"33","author":"Wang","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0039","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kose\u0142a-Paterczyk","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0040","doi-asserted-by":"crossref","unstructured":"Kendal J, Peterson N, Savjani R, et al. Surgical outcomes in patients treated with 5-day preoperative radiotherapy for primary soft tissue sarcoma. 2022.","DOI":"10.1016\/j.ijrobp.2023.06.2386"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0041","article-title":"Is 5 the New 25? long-term oncologic outcomes from a phase II, prospective, 5-fraction preoperative radiation therapy trial in patients with localized soft tissue sarcoma","volume":"7","author":"Bedi","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0042","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2021.06.027","article-title":"Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities","volume":"161","author":"Leite","year":"2021","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0043","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S1470-2045(22)00638-6","article-title":"Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): A single-centre, open-label, single-arm, phase 2 trial","volume":"23","author":"Guadagnolo","year":"2022","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0044","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0360-3016(95)00229-R","article-title":"Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology","volume":"33","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2023.12.003_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.21873\/invivo.11042","article-title":"Assessment of radiobiological \u03b1\/\u03b2 ratio in lung cancer and fibroblast cell lines using viability assays","volume":"31","author":"Karagounis","year":"2017","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0046","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-012-2797-1","article-title":"Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: Importance of tumor proximity to skin surface","volume":"20","author":"Baldini","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2023.12.003_bib0047","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/02841868809090331","article-title":"Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage","volume":"27","author":"Overgaard","year":"1988","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.semradonc.2023.12.003_bib0048","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/cncr.27951","article-title":"Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma","volume":"119","author":"O'Sullivan","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0049","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","article-title":"Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where?","volume":"84","author":"Haas","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0050","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejso.2018.09.001","article-title":"Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas","volume":"45","author":"Lansu","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0051","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mpo.10338","article-title":"Radiation-therapy effects on bone density","volume":"41","author":"Hopewell","year":"2003","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0052","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2008.12.006","article-title":"Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: Relationship to irradiated bone length, volume, tumor location and dose","volume":"75","author":"Dickie","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0053","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.prro.2015.09.004","article-title":"Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity: Can the risk be mitigated?","volume":"6","author":"Bishop","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0054","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0360-3016(91)90053-7","article-title":"Fraction size in external beam radiation therapy in the treatment of melanoma","volume":"20","author":"Sause","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0360-3016(94)90351-4","article-title":"Postoperative radiotherapy for cutaneous melanoma of the head and neck region","volume":"30","author":"Ang","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0056","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(09)70043-9","article-title":"Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma","volume":"10","author":"Guadagnolo","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.semradonc.2023.12.003_bib0057","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/cncr.28415","article-title":"The role of adjuvant radiotherapy in the local management of desmoplastic melanoma","volume":"120","author":"Guadagnolo","year":"2014","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.semradonc.2023.12.003_bib0058","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1245\/ASO.2004.12.039","article-title":"A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma","volume":"11","author":"Ballo","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2023.12.003_bib0059","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2005.06.030","article-title":"Combined-modality therapy for patients with regional nodal metastases from melanoma","volume":"64","author":"Ballo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0060","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ijrobp.2008.06.1910","article-title":"Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma","volume":"73","author":"Beadle","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.semradonc.2023.12.003_bib0061","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","article-title":"Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial","volume":"16","author":"Henderson","year":"2015","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.semradonc.2023.12.003_bib0062","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2023.12.003_bib0063","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdh058","article-title":"Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas","volume":"15","author":"Ray-Coquard","year":"2004","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2023.12.003_bib0064","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2017.12.262","article-title":"Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas","volume":"100","author":"Venigalla","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2023.12.003_bib0065","series-title":"Limb Salvage in Musculoskeletal Oncology","first-page":"626","article-title":"Modification of the system for functional evaluation of the surgical management of musculoskeletal tumors","author":"Enneking","year":"1987"},{"issue":"286","key":"10.1016\/j.semradonc.2023.12.003_bib0066","first-page":"241","article-title":"A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system","author":"Enneking","year":"1993","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0067","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00540024","article-title":"Development of a measure of physical function for patients with bone and soft tissue sarcoma","volume":"5","author":"Davis","year":"1996","journal-title":"Qual Life Res"},{"issue":"358","key":"10.1016\/j.semradonc.2023.12.003_bib0068","first-page":"90","article-title":"Evaluating functional outcome in patients with lower extremity sarcoma","author":"Davis","year":"1999","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.semradonc.2023.12.003_bib0069","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.semradonc.2023.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.21.02810","article-title":"The time toxicity of cancer treatment","volume":"40","author":"Gupta","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2023.12.003_bib0071","doi-asserted-by":"crossref","first-page":"OP2200737","DOI":"10.1200\/OP.22.00737","article-title":"Evaluating the time toxicity of cancer treatment in the CCTG CO.17 Trial","volume":"19","author":"Gupta","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.semradonc.2023.12.003_bib0072","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.trecan.2023.01.006","article-title":"The unequal burden of time toxicity","volume":"9","author":"Johnson","year":"2023","journal-title":"Trends Cancer"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429623000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429623000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T11:07:07Z","timestamp":1710846427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429623000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1053429623000887"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2023.12.003","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}